AbbVie Acquires Apogee for $10.9 Billion to Add Inflammatory Disease Drug

AbbVie has agreed to buy Apogee for $10.9 billion, securing an inflammatory disease drug in the drugmaker's largest acquisition in more than half a decade. The transaction arrives as merger and acquisition activity across the…